Archan Ruparel is a panelist on “Pharma under the antitrust microscope,” and will discuss legal and economic aspects of newer, less explored antitrust theories such as alleged harm from reduced innovation, bundled rebates, inappropriate patent listings, and self-preferencing PBM practices.
Elizabeth Bailey is a moderator and Carl Shapiro is a panelist on “Has competition in the US been declining?.” Many believe that the US economy has suffered from widespread decline in competitiveness, measured by increasing concentration or markups. Several economic papers have studied this topic rigorously. What does the empirical evidence show, and what are the implications for antitrust policy?
For more information on this event, click here.
